Close Menu

NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market on Thursday that its first quarter revenues rose 4 percent year over year, thanks largely to high demand for certain molecular diagnostic services that pushed its clinical lab revenues up 9 percent during the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.